These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12669549)

  • 41. [The mechanisms responsible for the therapeutic effects of anti-Fas ligand antibody on viral myocarditis in mice].
    Chang H; Han B; Han XZ
    Zhonghua Er Ke Za Zhi; 2005 Dec; 43(12):920-4. PubMed ID: 16412356
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The HLA system and Coxsackie B viral myocarditis in adults].
    Gladkova ND; Vostokova AA; Zvereva KV; Sibiriakova LG; Pevnitskiĭ LA
    Kardiologiia; 1986 Dec; 26(12):24-8. PubMed ID: 3031353
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A case of myocarditis following neonatal meningitis caused by coxsackievirus B1 in spite of intravenous immunoglobulin treatment.
    Bae EY; Lee EJ; Han SB; Lee JY; Jeong DC; Kang JH
    J Trop Pediatr; 2014 Apr; 60(2):164-7. PubMed ID: 24122863
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vivo delivery of interleukin-35 relieves coxsackievirus-B3-induced viral myocarditis by inhibiting Th17 cells.
    Hu Y; Dong C; Yue Y; Xiong S
    Arch Virol; 2014 Sep; 159(9):2411-9. PubMed ID: 24788848
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Coxsackie B virus infection].
    Panaszek B; Wrzyszcz M; Małolepszy J
    Pol Tyg Lek; 1990 Sep 3-10; 45(36-37):752-4. PubMed ID: 1964729
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Acute myocarditis due to Coxsackie virus B3 in two infants].
    van der Meulen M; van Doornum GJ; Corel LJ; Dalinghaus M; Fraaij PL; de Hoog M
    Ned Tijdschr Geneeskd; 2009; 153():A152. PubMed ID: 19785892
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Truncated monocyte chemoattractant protein-1 can alleviate cardiac injury in mice with viral myocarditis via infiltration of mononuclear cells.
    Shen Y; Zhang FQ; Wei X
    Microbiol Immunol; 2014 Mar; 58(3):195-201. PubMed ID: 24401088
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Beneficial effects of captopril in coxsackievirus myocarditis.
    Matsumori A; Suzuki H; Kawai C
    Circulation; 1990 Nov; 82(5):1882-3. PubMed ID: 2171809
    [No Abstract]   [Full Text] [Related]  

  • 49. [Clinical and experimental studies on huodan tablet in treating pediatric viral myocarditis].
    Li Q; Chen G; Wei Y
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1999 Aug; 19(8):453-6. PubMed ID: 11783221
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection of enteroviral RNA on Guthrie card dried blood of a neonate with fatal Coxsackie B3 myocarditis on day 17.
    Smets K; Keymeulen A; Wollants E; Lagrou K; Van Ranst M; Padalko E
    J Clin Virol; 2008 Jun; 42(2):207-10. PubMed ID: 18316244
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of prednisolone on acute viral myocarditis in mice.
    Tomioka N; Kishimoto C; Matsumori A; Kawai C
    J Am Coll Cardiol; 1986 Apr; 7(4):868-72. PubMed ID: 3007597
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interleukin-27 ameliorates coxsackievirus-B3-induced viral myocarditis by inhibiting Th17 cells.
    Zhu H; Lou C; Liu P
    Virol J; 2015 Nov; 12():189. PubMed ID: 26578236
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of Astragulas membranaceus on natural killer cell activity and induction of alpha- and gamma-interferon in patients with Coxsackie B viral myocarditis.
    Yang YZ; Jin PY; Gúo Q; Wang QD; Li ZS; Ye YC; Shan YF; Zhao HY; Zhu JR; Pu SY
    Chin Med J (Engl); 1990 Apr; 103(4):304-7. PubMed ID: 2167822
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Idiopathic giant cell myocarditis: case report.
    Isaacs RD; Roche AH; Smeeton WM; Ali MR; Croxson MC
    N Z Med J; 1986 May; 99(802):360-1. PubMed ID: 3022212
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Coxsackie B5 infection in a newborn infant. Meningoencephalitis and myocarditis].
    Lauras B; Valla Y; Gaudin O; Teyssier G; Rayet I
    Pediatrie; 1984; 39(7):561-5. PubMed ID: 6100130
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Idiopathic dilated cardiomyopathy as a late complication of healed viral (Coxsackie B virus) myocarditis: historical analysis, review of the literature, and a postulated unifying hypothesis.
    Spotnitz MD; Lesch M
    Prog Cardiovasc Dis; 2006; 49(1):42-57. PubMed ID: 16867849
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 50 Years ago in The Journal of Pediatrics: myocarditis possibly due to coxsackie group A, type 16 virus.
    Toltzis P
    J Pediatr; 2013 May; 162(5):992. PubMed ID: 23617972
    [No Abstract]   [Full Text] [Related]  

  • 58. Coxsackie virus and rheumatic fever. A correlative study.
    Suresh L; Chandrasekar S; Rao RS; Ravi V; Badrinath S
    J Assoc Physicians India; 1989 Sep; 37(9):582-5. PubMed ID: 2561125
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice.
    Schmidtke M; Merkle I; Klingel K; Hammerschmidt E; Zautner AE; Wutzler P
    J Med Virol; 2007 Sep; 79(9):1334-42. PubMed ID: 17607777
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An assessment of thymosine in the treatment of patients suffering from myocarditis with decreased cell-mediated-immunity.
    Chen SX; Yu GR; Bao SH; Mei SW; Zang DL; Zheng DS; Huang MX; Zhou GY; Lu PH; Sai FL
    Chin Med J (Engl); 1985 Nov; 98(11):841-6. PubMed ID: 3009100
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.